名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
Context Therapeutics Inc | CNTX | NASDAQ | 普通株式 |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
1.33 | 1.30 | 1.36 | 1.3444 | 1.37 |
最新ニュース
日付 | 時間 | ソース | タイトル |
---|---|---|---|
2024/4/01 | 20:30 | GLOBE | Context Therapeutics Submits IND Application to Evaluate.. |
2024/3/21 | 20:43 | GLOBE | Context Therapeutics Reports Full Year 2023 Operating and.. |
2024/3/06 | 21:30 | EDGAR2 | Form 8-K - Current report |
2024/2/08 | 06:24 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
2023/11/10 | 06:15 | GLOBE | Context Therapeutics Reports Third Quarter 2023 Operating.. |
2023/11/10 | 06:04 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2023/10/31 | 22:04 | EDGAR2 | Form 8-K - Current report |
2023/10/31 | 22:00 | GLOBE | Context Therapeutics Announces Preclinical Data.. |
2023/9/27 | 22:00 | GLOBE | Context Therapeutics Announces Acceptance of Abstract to be.. |
2023/8/10 | 05:10 | GLOBE | Context Therapeutics Reports Second Quarter 2023 Operating.. |
2023/8/10 | 05:04 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2023/8/07 | 21:11 | EDGAR2 | Form 8-K - Current report |
2023/8/01 | 20:30 | GLOBE | Context Therapeutics to Participate in Two August 2023.. |
2023/5/11 | 05:39 | GLOBE | Context Therapeutics Reports First Quarter 2023 Operating.. |